glp-1 europe Agonists Weight Loss Drugs Market Size & Outlook, 2030 Europe set to get first

These combined effects lead to reduced food cravings, slower digestion, and improved overall metabolic health

Article 7 mins Intellectual Property Insurance: Dispelling the Myths and Misconceptions In a landscape where IP is increasingly becoming integral to company valuations, many business leaders, boards, patent attorneys and litigation teams are making IP insurance a key asset in their toolkits

As for online channels, none of the most prominent telehealth platforms (e.g., Hims, Hers, Strut Health) carry Selank

Yes, these drugs were originally developed for type 2 diabetes but are now widely used for weight management because they reliably reduce appetite and induce significant weight loss

Nesterowicz et al., 2023)